| Journal | The Journal of pharmacology and experimental therapeutics |
| Study Type | Clinical Study |
| Population | Human participants |
This longitudinal study addresses a critical clinical gap where conventional spasticity treatments often fail patients due to poor efficacy or intolerable side effects. The differentiation between spasticity and spasm patient populations provides nuanced insights for targeted therapeutic approaches.
This observational study followed 150 patients with muscle spasticity or spasms using various cannabis products, tracking Patient Reported Outcome Measures over time. While no improvements in physical functioning were observed across product types, patients with spasticity using CBD-only products showed meaningful improvements in sleep disturbance, fatigue, pain interference, and pain intensity. The study appears to be cut off mid-sentence regarding spasm patients using balanced products, limiting complete interpretation of findings.
“The lack of physical functioning improvement is sobering but not surprising – spasticity is notoriously difficult to treat objectively. However, the sleep and pain improvements with CBD-only products in spasticity patients align with what I observe clinically and represent meaningful quality of life gains.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- Does medicinal cannabis improve physical functioning in patients with muscle spasticity or spasms?
- Which cannabis products showed the most benefit for spasticity symptoms?
- Is there a difference in cannabis effectiveness between spasticity and spasm patients?
- What are the main limitations of current conventional treatments for muscle spasticity and spasms?
- How robust is the evidence from this cannabis spasticity study?
FAQ
Does medicinal cannabis improve physical functioning in patients with muscle spasticity or spasms?
No, this study found no improvements in physical functioning for patients with either spasticity or spasms across all cannabis product types. The benefits observed were primarily in symptom management rather than functional capacity.
Which cannabis products showed the most benefit for spasticity symptoms?
CBD-only products demonstrated significant benefits for patients with spasticity, particularly improving sleep disturbance, fatigue, pain interference, and pain intensity. This suggests CBD may be more effective than other cannabis formulations for spasticity-related symptoms.
Is there a difference in cannabis effectiveness between spasticity and spasm patients?
Yes, the study indicates different response patterns between these patient groups. While spasticity patients showed improvements with CBD-only products, the study data for spasm patients appears incomplete in the provided summary, suggesting potentially different treatment responses.
What are the main limitations of current conventional treatments for muscle spasticity and spasms?
According to this research, conventional pharmacological treatments have poor effectiveness and/or tolerability profiles. This treatment gap significantly impacts patients’ quality of life and explains why cannabis is being explored as an alternative therapeutic option.
How robust is the evidence from this cannabis spasticity study?
This was an observational longitudinal study with 150 patients reporting adverse events and 78 reporting outcomes, using validated Patient Reported Outcome Measures. While providing valuable real-world data, the observational design limits causal conclusions compared to randomized controlled trials.